GRPH
Price:
$3.18
Market Cap:
$185.19M
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 20...[Read more]
Industry
Biotechnology
IPO Date
2021-06-25
Stock Exchange
NASDAQ
Ticker
GRPH
According to Graphite Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -57.96%. This represents a change of 309.76% compared to the average of -14.15% of the last 4 quarters.
The mean historical ROE of Graphite Bio, Inc. over the last ten years is -17.34%. The current -57.96% ROE has changed 234.20% with respect to the historical average. Over the past ten years (40 quarters), GRPH's ROE was at its highest in in the December 2020 quarter at 97.14%. The ROE was at its lowest in in the June 2023 quarter at -24.68%.
Average
-17.34%
Median
-15.55%
Minimum
-67.90%
Maximum
20.76%
Discovering the peaks and valleys of Graphite Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.65%
Maximum Annual ROE = 20.76%
Minimum Annual Increase = -174.88%
Minimum Annual ROE = -67.90%
Year | ROE | Change |
---|---|---|
2023 | -67.90% | 108.55% |
2022 | -32.56% | 109.41% |
2021 | -15.55% | -174.88% |
2020 | 20.76% | 143.65% |
The current ROE of Graphite Bio, Inc. (GRPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-38.67%
5-year avg
-17.34%
10-year avg
-17.34%
Graphite Bio, Inc.’s ROE is greater than Assembly Biosciences, Inc. (-121.46%), greater than Instil Bio, Inc. (-37.44%), greater than Nuvation Bio Inc. (-108.68%), greater than Achilles Therapeutics plc (-54.57%), greater than NextCure, Inc. (-62.50%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Sensei Biotherapeutics, Inc. (-53.86%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%),
Company | ROE | Market cap |
---|---|---|
-121.46% | $93.95M | |
-37.44% | $142.26M | |
-108.68% | $942.35M | |
-54.57% | $46.82M | |
-62.50% | $25.21M | |
-8.54% | $8.20M | |
-41.34% | $83.74M | |
-53.86% | $11.42M | |
-35.28% | $223.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graphite Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Graphite Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Graphite Bio, Inc.'s ROE?
How is the ROE calculated for Graphite Bio, Inc. (GRPH)?
What is the highest ROE for Graphite Bio, Inc. (GRPH)?
What is the 3-year average ROE for Graphite Bio, Inc. (GRPH)?
What is the 5-year average ROE for Graphite Bio, Inc. (GRPH)?
How does the current ROE for Graphite Bio, Inc. (GRPH) compare to its historical average?